Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Seagen Inc (NQ: SGEN )

214.16 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Seagen Inc

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Why Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Lucira Health, Inc. (NASDAQ: LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test. 
Via Benzinga
Analyst Cautions Investors On Overreacting To 'Early-Stage' Pfizer/Seagen Discussions
Via Benzinga
UNP Stock Alert: What to Know as Union Pacific’s CEO Steps Down
Union Pacific (UNP) stock is a hot topic among traders on Monday as its CEO prepares to step down this year to make room for a replacement. 
Via InvestorPlace
JMP Securities Maintains Market Outperform Rating for Seagen: Here's What You Need To Know
Via Benzinga
Why Seagen Stock Is Soaring Today
Investors and analysts liked what they heard in the company's Q4 update. 
Via The Motley Fool
Seagen (SGEN) Q4 2022 Earnings Call Transcript
SGEN earnings call for the period ending December 31, 2022. 
Via The Motley Fool
The $30 Billion Reason Seagen (SGEN) Stock Is Up 11% Today
SGEN stock is climbing about 11% in early trading. Pfizer is reportedly interested in buying the biotech for its line of cancer treatments. 
Via InvestorPlace
Union Pacific, Kosmos Energy, Fisker And Other Big Stocks Moving Higher On Monday
U.S. stocks traded higher, with the Dow Jones gaining more than 300 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
'Here We Go Again': Seagen Soars As Pfizer Reportedly Mulls A Takeover
The potential deal follows rumors last year that Merck could buy Seagen. 
Via Investor's Business Daily
Seagen Stock Soars On Pfizer Takeover Talks: What's Going On?
Seagen Inc (NASDAQ: SGEN) shares are trading higher Monday following reports indicating pharmaceutical giant Pfizer Inc (NYSE: 
Via Benzinga
Li Auto Powers Up, but Another Stock Is Really Stepping on the Gas
The stock market looked poised to climb on Monday morning. 
Via The Motley Fool
8 Analysts Have This to Say About Seagen
Via Benzinga
Analyst Ratings for Seagen
Via Benzinga
Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket
Gainers Lucira Health, Inc. (NASDAQ: LHDX) rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off Monday with a breakdown of the biggest pre-market stock movers investors will want to keep an eye on! 
Via InvestorPlace
Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk
US stocks are coming off a lackluster week and early indications suggest a reversal in sentiment in the new trading week. While rising bond yields could be a cause of concern, the recent weakness could... 
Via Benzinga
Seagen, Occidental Petroleum And 3 Stocks To Watch Heading Into Monday
With US futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Pfizer In Early Talks To Buy Cancer-Focused Seagen: WSJ
Via Benzinga
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash. 
Via Benzinga
Analysts Are Bullish On Seagen's Catalyst-Rich Pipeline, Finding No Problem With No M&A
Via Benzinga
KBR, Twilio, Roku And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Seattle Genetics' 'Refreshing' Enthusiasm Drives Stock Surge; Alkermes Briefly Breaks Out
Seattle Genetics' guidance deliberately excludes a looming opportunity for Padcev. 
Via Investor's Business Daily
Pagaya Technologies To Rally Around Over 120%? Here Are 10 Other Analyst Forecasts For Thursday
Keybanc boosted the price target for Twilio Inc. (NYSE: TWLO) from $77 to $89. Keybanc analyst Thomas Blakey maintained an Overweight rating on the stock. Twilio shares gained 6.4% to close at $66.05... 
Via Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2023
These stocks may soon start turning heads with their revenue growth. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
Via Benzinga
RH To Rally Over 15%? Here Are 10 Other Analyst Forecasts For Monday
Citigroup boosted the price target for RH (NYSE: RH) from $305 to $380. Citigroup analyst Steven Zaccone maintained a Buy rating. Hershey shares fell 4% to $330.00 in pre-market trading. 
Via Benzinga
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new... 
Via Benzinga
Union Pacific To Rally Over 11%? Here Are 10 Other Analyst Forecasts For Wednesday
Keybanc raised the price target for Reliance Steel & Aluminum Co. (NYSE: RS) from $225 to $235. Keybanc analyst Philip Gibbs maintained an Overweight rating. Reliance Steel shares fell 0.2% to close at... 
Via Benzinga
Seagen's Tukysa Becomes First FDA-Approved Treatment For HER2-Positive Metastatic Colorectal Cancer
Via Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Biopharma stocks were not immune to the broader market downturn seen for much of 2022. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.